Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Org Biomol Chem ; 14(26): 6205-11, 2016 Jul 14.
Artículo en Inglés | MEDLINE | ID: mdl-27282129

RESUMEN

Dehydroascorbate is a by-product of copper-catalysed azide-alkyne click (CuAAC) reactions and also forms advanced glycation end products (AGEs) in tissues undergoing oxidative stress. Here we isolate and characterize an arginine-dehydroascorbate adduct formed during CuAAC reactions, investigate strategies for preventing its formation, and propose its biological relevance as an AGE.


Asunto(s)
Alquinos/química , Arginina/química , Azidas/química , Cobre/química , Ácido Deshidroascórbico/síntesis química , Productos Finales de Glicación Avanzada/síntesis química , Catálisis , Química Clic , Ácido Deshidroascórbico/química , Productos Finales de Glicación Avanzada/química , Estructura Molecular
2.
Angew Chem Int Ed Engl ; 54(44): 13095-100, 2015 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-26336938

RESUMEN

The design of inhibitors of protein-protein interactions mediating amyloid self-assembly is a major challenge mainly due to the dynamic nature of the involved structures and interfaces. Interactions of amyloidogenic polypeptides with other proteins are important modulators of self-assembly. Here we present a hot-segment-linking approach to design a series of mimics of the IAPP cross-amyloid interaction surface with Aß (ISMs) as nanomolar inhibitors of amyloidogenesis and cytotoxicity of Aß, IAPP, or both polypeptides. The nature of the linker determines ISM structure and inhibitory function including both potency and target selectivity. Importantly, ISMs effectively suppress both self- and cross-seeded IAPP self-assembly. Our results provide a novel class of highly potent peptide leads for targeting protein aggregation in Alzheimer's disease, type 2 diabetes, or both diseases and a chemical approach to inhibit amyloid self-assembly and pathogenic interactions of other proteins as well.


Asunto(s)
Péptidos beta-Amiloides/antagonistas & inhibidores , Diseño de Fármacos , Polipéptido Amiloide de los Islotes Pancreáticos/farmacología , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/química , Péptidos beta-Amiloides/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Humanos , Polipéptido Amiloide de los Islotes Pancreáticos/química , Agregado de Proteínas/efectos de los fármacos , Propiedades de Superficie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA